FORM N-PX PROXY VOTING RECORD

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 COLUMN 9 COLUMN 10 COLUMN 11 COLUMN 12 COLUMN 13 COLUMN 14 COLUMN 15
NAME   OF   ISSUER
CUSIP ISIN FIGI MEETING   DATE VOTE   DESCRIPTION VOTE   CATEGORY DESCRIPTION   OF   OTHER  CATEGORY VOTE   SOURCE SHARES   VOTED SHARES   ON   LOAN DETAILS   OF   VOTE MANAGER   NUMBER SERIES   ID OTHER   INFO
HOW   VOTED SHARES  VOTED FOR   OR   AGAINST   MANAGEMENT
Vacasa, Inc. 91854V206 US91854V2060 - 04/29/2025 Adoption of the Agreement and Plan of Merger, dated as of December 30, 2024, by and among Vacasa, Inc. (the "Company"), Vacasa Holdings LLC, Casago Holdings, LLC, Vista Merger Sub II Inc. and Vista Merger Sub LLC, as amended by Amendment No. 1 thereto dated as of March 17, 2025, Amendment No. 2 thereto dated as of March 28, 2025, and as may be further amended, modified or supplemented from time to time (the "Merger Agreement"), and to waive any applicable provision of Section 5.1(d) of the Company's certificate of incorporation; and EXTRAORDINARY TRANSACTIONS
- ISSUER 511.000000 0 FOR
511.000000
FOR
- -
Vacasa, Inc. 91854V206 US91854V2060 - 04/29/2025 Adjournment of the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
- ISSUER 511.000000 0 FOR
511.000000
FOR
- -
FIGS, Inc. 30260D103 US30260D1037 - 06/04/2025 Election of Directors: Catherine Spear DIRECTOR ELECTIONS
- ISSUER 3754.000000 0 WITHHOLD
3754.000000
AGAINST
- -
FIGS, Inc. 30260D103 US30260D1037 - 06/04/2025 Election of Directors: Sheila Antrum DIRECTOR ELECTIONS
- ISSUER 3754.000000 0 WITHHOLD
3754.000000
AGAINST
- -
FIGS, Inc. 30260D103 US30260D1037 - 06/04/2025 Election of Directors: Mario Marte DIRECTOR ELECTIONS
- ISSUER 3754.000000 0 FOR
3754.000000
FOR
- -
FIGS, Inc. 30260D103 US30260D1037 - 06/04/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
- ISSUER 3754.000000 0 FOR
3754.000000
FOR
- -
FIGS, Inc. 30260D103 US30260D1037 - 06/04/2025 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
- ISSUER 3754.000000 0 FOR
3754.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Transaction Proposal - To consider and vote on a proposal to approve and adopt the Transaction Agreement, dated as of March 13, 2025, by and among Endo, Mallinckrodt plc, a public limited company incorporated in Ireland with registered number 522227 ("Mallinckrodt"), and Salvare Merger Sub LLC, a Delaware limited liability company and wholly owned subsidiary of Mallinckrodt ("Merger Sub"), as it may be amended, supplemented, or otherwise modified from time to time (the "Transaction Agreement"), including the plan of merger contained therein, and the transactions contemplated thereby (the "Transactions"), including the merger of Merger Sub with and into Endo, with Endo continuing as the surviving corporation (the "Business Combination"), which is further described in the sections of the accompanying joint proxy statement/prospectus (the "joint proxy statement/prospectus") entitled "The Transaction" and "The Transaction Agreement" beginning on page 111 and page 305, respectively, of the joint proxy statement/prospectus and a copy of which is attached as Annex B to the joint proxy statement/prospectus. EXTRAORDINARY TRANSACTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Distributable Reserves Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve (i) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account as at the date of the joint proxy statement/prospectus (being the first Mallinckrodt distributable reserves creation); and (ii) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account following the consummation of the Business Combination, (including but not limited to the share premium arising from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement or the amounts credited to Mallinckrodt's share premium account upon the capitalization of any merger reserve or like reserve resulting from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement) (being the second Mallinckrodt distributable reserves creation). CAPITAL STRUCTURE
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Combination-Related Compensation Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve compensation that will or may become payable by Endo to its named executive officers in connection with the Transactions. SECTION 14A SAY-ON-PAY VOTES
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Mallinckrodt Articles Amendment Proposals - To consider and vote on, on a non-binding, advisory basis, eight separate proposals to approve the following amendments to the Mallinckrodt articles of association, presented separately in accordance with the requirements of the United States Securities and Exchange Commission: Change in Mallinckrodt Capital Structure - To vary the authorized share capital of Mallinckrodt, including through the creation of a new class of preferred shares, the removal of pre-emption rights of certain shareholders over newly issued shares and the deletion of Article 174 of the existing Mallinckrodt constitution, which capped the total number of shares issuable pursuant to Mallinckrodt's management incentive plan at 10%, as shown in Annex K-2 of the joint proxy statement/prospectus; CAPITAL STRUCTURE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Dealings in Transfers and Registration of Mallinckrodt Shares - To delete certain restrictions on Mallinckrodt shareholders' ability to deal in their Mallinckrodt shares, amend the circumstances in which directors can decline to register a transfer of shares and eliminate the drag-along rights and tag-along rights in the existing memorandum and articles of association of Mallinckrodt, as shown in Annex K-3 of the joint proxy statement/prospectus; SHAREHOLDER RIGHTS AND DEFENSES
CAPITAL STRUCTURE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Change in Mallinckrodt Shareholder Meeting Procedure - To change the quorum required for general meetings (to two or more persons holding (or representing by proxy) at least one half in nominal value of the issued shares of an applicable class), the manner in which voting will be conducted (by requiring voting to be carried out by way of a poll) and the procedures required for advance notice of members' business and nominations (by aligning with the customary current approach by U.S. listed companies), as shown in Annex K-4 of the joint proxy statement/prospectus: CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Transactions involving Mallinckrodt - To delete the ability of holders of more than one half of the Mallinckrodt shares to require the Mallinckrodt board to initiate a process for a review of strategic alternatives and a sale of assets or business segments, to delete restrictions on the Mallinckrodt board from selling, leasing or exchanging all or substantially all of Mallinckrodt's property and assets without prior consent of the holders of more than one half of the Mallinckrodt shares, to amend provisions regarding shareholder rights plan to align with the customary approach adopted by Irish incorporated U.S. listed companies and to restrict Mallinckrodt from engaging in business combinations with "interested members" for a period of time, subject to certain exceptions, as shown in Annex K-5 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Proceedings of Mallinckrodt Directors - To permit the Mallinckrodt board to determine its own size (subject to a minimum of two and a maximum of twenty directors) and its own chair, and to allow for the vacation ipso facto of the office of a director where he or she is requested to resign in writing by not less than three quarters of the other directors, as shown in Annex K-6 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Appointment and Removal of Mallinckrodt Directors - To change the provisions regarding appointment of Mallinckrodt directors and add provisions regarding plurality voting of directors, as shown in Annex K-7 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Information Rights and Board Observers - To delete existing provisions in respect of information rights and board observers for certain shareholders, as shown in Annex K-8 of the joint proxy statement/prospectus; and CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Miscellaneous Changes - To make certain other changes to make Mallinckrodt's articles of association in a form that is customary for an Irish public limited company effecting a transaction of the nature of the Transactions and for a potential listing of Mallinckrodt's shares on the New York Stock Exchange, as shown in Annex K-9 of the joint proxy statement/prospectus. CORPORATE GOVERNANCE
- ISSUER 9946.000000 0 AGAINST
9946.000000
AGAINST
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Efron DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Herendeen DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Scott Hirsch DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Sophia Langlois DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Andy Pasternak DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Marc Yoskowitz DIRECTOR ELECTIONS
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay). SECTION 14A SAY-ON-PAY VOTES
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve, on an advisory basis, the frequency of soliciting an advisory say-on-pay vote (say-on-frequency). SECTION 14A SAY-ON-PAY VOTES
- ISSUER 9946.000000 0 ONE YEAR
9946.000000
FOR
- -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm's remuneration. AUDIT-RELATED
- ISSUER 9946.000000 0 FOR
9946.000000
FOR
- -

[Repeat as Necessary]